pharma · Breast Cancer · Prostate Cancer · UTHR
United Therapeutics Europe
United Therapeutics Europe Ltd
United Therapeutics is a pharma organization headquartered in Silver Spring, USA. It trades on NYSE under ticker UTHR. Primary therapeutic focus areas include Breast Cancer, Prostate Cancer, Pulmonary Arterial Hypertensi
1000 Spring Street, Silver Spring, Maryland 20910, US HQ
1996 Founded
1,443 Employees
Public company Type
UTHR · NYSE Ticker
Company details
- Status
- Public
- HQ
- 1000 Spring Street, Silver Spring, Maryland 20910, US
- Founded
- 1996
- Employees
- 1,443
- Programs
- 1032
- Drugs
- 612
- Patents
- 3720
emtricitabine/tenofovir alafenamide
Phase 2 · small molecule · Acceptability of Health Care
emtricitabine/tenofovir alafenamide for Acceptability of Health Care is a Phase 2 program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Internal code CONRAD B20-151
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- United Therapeutics Europe Ltd
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Acceptability of Health Care
- Status
- completed
- Trials
- 1